146 related articles for article (PubMed ID: 29661425)
1. Soluble CD30, Acute Rejection, and Graft Survival: Pre- and 6-Month Post-Transplant Determinations-When Is the Best Time to Measure?
de Holanda MI; Matuck T; de Carvalho DDBM; Domingues EMFL; Curvo R; Glasberg DS; Santos AMG; Borela ÁM; Pôrto LC
Transplant Proc; 2018 Apr; 50(3):728-736. PubMed ID: 29661425
[TBL] [Abstract][Full Text] [Related]
2. Pre-transplant and post-transplant soluble CD30 for prediction and diagnosis of acute kidney allograft rejection.
Nafar M; Farrokhi F; Vaezi M; Entezari AE; Pour-Reza-Gholi F; Firoozan A; Eniollahi B
Int Urol Nephrol; 2009; 41(3):687-93. PubMed ID: 19142743
[TBL] [Abstract][Full Text] [Related]
3. Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long-Term Allograft Function, and Patients' Survival.
Trailin AV; Ostapenko TI; Nykonenko TN; Nesterenko SN; Nykonenko OS
Dis Markers; 2017; 2017():9264904. PubMed ID: 28694560
[TBL] [Abstract][Full Text] [Related]
4. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
Kamali K; Abbasi MA; Farokhi B; Abbasi A; Fallah P; Seifee MH; Ghadimi N; Rezaie AR
Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374
[TBL] [Abstract][Full Text] [Related]
5. Serial soluble CD30 measurements as a predictor of kidney graft outcome.
Halim MA; Al-Otaibi T; Al-Muzairai I; Mansour M; Tawab KA; Awadain WH; Balaha MA; Said T; Nair P; Nampoory MR
Transplant Proc; 2010 Apr; 42(3):801-3. PubMed ID: 20430176
[TBL] [Abstract][Full Text] [Related]
6. Post-transplant monitoring of soluble CD30 level as predictor of graft outcome: a single center experience from China.
Wang D; Wu W; Yang S; Wang Q; Tan J
Transpl Immunol; 2012 Dec; 27(4):146-50. PubMed ID: 23079227
[TBL] [Abstract][Full Text] [Related]
7. Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection.
Wang D; Wu GJ; Wu WZ; Yang SL; Chen JH; Wang H; Lin WH; Wang QH; Zeng ZX; Tan JM
Transpl Immunol; 2007 Jun; 17(4):278-82. PubMed ID: 17493531
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD30 as a predictor of kidney graft outcome.
Pelzl S; Opelz G; Wiesel M; Schnülle P; Schönemann C; Döhler B; Süsal C
Transplantation; 2002 Jan; 73(1):3-6. PubMed ID: 11792970
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD30 in renal transplant recipients: is it a good biomarker to predict rejection?
Azarpira N; Aghdaie MH; Malekpour Z
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):31-6. PubMed ID: 20061689
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
[TBL] [Abstract][Full Text] [Related]
11. Pre-transplant soluble CD30 level as a predictor of not only acute rejection and graft loss but pneumonia in renal transplant recipients.
Wang D; Wu WZ; Chen JH; Yang SL; Wang QH; Zeng ZX; Tan JM
Transpl Immunol; 2010 Feb; 22(3-4):115-20. PubMed ID: 20036333
[TBL] [Abstract][Full Text] [Related]
12. Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30.
Süsal C; Pelzl S; Döhler B; Opelz G
J Am Soc Nephrol; 2002 Jun; 13(6):1650-6. PubMed ID: 12039995
[TBL] [Abstract][Full Text] [Related]
13. Pretransplantation soluble CD30 level as a predictor of acute rejection in kidney transplantation: a meta-analysis.
Chen Y; Tai Q; Hong S; Kong Y; Shang Y; Liang W; Guo Z; He X
Transplantation; 2012 Nov; 94(9):911-8. PubMed ID: 23052636
[TBL] [Abstract][Full Text] [Related]
14. [Serum soluble HLA-G, soluble CD30 is correlated to the time after transplantation in renal transplant recipients].
Jin Z; Xu C; Duan W; Yang J; Tian P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jul; 33(7):947-952. PubMed ID: 28712403
[TBL] [Abstract][Full Text] [Related]
15. High serum level of the soluble CD30 identifies Chinese kidney transplant recipients at high risk of unfavorable outcome.
Iv R; He Q; Wang HP; Jin J; Chen Y; Chen JH
Transplant Proc; 2008 Dec; 40(10):3375-80. PubMed ID: 19100393
[TBL] [Abstract][Full Text] [Related]
16. Relation between pretransplant serum levels of soluble CD30 and acute rejection during the first 6 months after a kidney transplant.
Shooshtarizadeh T; Mohammadali A; Ossareh S; Ataipour Y
Exp Clin Transplant; 2013 Jun; 11(3):229-33. PubMed ID: 23477385
[TBL] [Abstract][Full Text] [Related]
17. High pre-transplant soluble CD30 levels are predictive of the grade of rejection.
Rajakariar R; Jivanji N; Varagunam M; Rafiq M; Gupta A; Sheaff M; Sinnott P; Yaqoob MM
Am J Transplant; 2005 Aug; 5(8):1922-5. PubMed ID: 15996240
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD30 and ELISA-detected human leukocyte antigen antibodies for the prediction of acute rejection in pediatric renal transplant recipients.
Billing H; Sander A; Süsal C; Ovens J; Feneberg R; Höcker B; Vondrak K; Grenda R; Friman S; Milford DV; Lucan M; Opelz G; Tönshoff B
Transpl Int; 2013 Mar; 26(3):331-8. PubMed ID: 23279372
[TBL] [Abstract][Full Text] [Related]
19. Pretransplant soluble CD30 level has limited effect on acute rejection, but affects graft function in living donor kidney transplantation.
Kim MS; Kim HJ; Kim SI; Ahn HJ; Ju MK; Kim HJ; Jeon KO; Kim YS
Transplantation; 2006 Dec; 82(12):1602-5. PubMed ID: 17198243
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD30, the Immune Response, and Acute Rejection in Human Kidney Transplantation: A Systematic Review and Meta-Analysis.
Mirzakhani M; Shahbazi M; Akbari R; Dedinská I; Nemati E; Mohammadnia-Afrouzi M
Front Immunol; 2020; 11():295. PubMed ID: 32256486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
